Core Viewpoint - Astrotech Corporation has initiated a review of strategic alternatives to maximize shareholder value, which may include raising equity capital, reverse mergers, combination transactions, and potential sales of parts of the business [1][3]. Group 1: Strategic Review - The Board of Directors is exploring various strategic options to enhance shareholder value without a set deadline for completion [3]. - Potential actions under consideration include raising equity capital, reverse mergers, and the sale of all or part of the Company's business [1]. Group 2: Business Confidence - The Company expresses confidence in its mass spectrometry and gas chromatography technologies, targeting large end markets such as explosives trace detection and environmental testing [2]. - Astrotech is advancing its strategic sales plans and customer relationships globally while considering options to scale the business effectively [2]. Group 3: Subsidiaries Overview - Astrotech operates through subsidiaries that focus on specialized markets: - 1st Detect develops trace detection systems for security and narcotics screening [5]. - AgLAB designs process analyzers for the agriculture industry [5]. - Pro-Control provides solutions for chemical process control in industrial manufacturing [5]. - EN-SCAN, Inc. offers portable environmental testing solutions integrating gas chromatography and mass spectrometry [5].

Company Overview - Astrotech Corporation is a mass spectrometry company that creates, operates, and scales innovative businesses through its wholly owned subsidiaries [3] - The company is headquartered in Austin, Texas [3] Subsidiaries and Their Focus - 1st Detect develops, manufactures, and markets trace detection systems for security and narcotics screening applications [4] - AgLAB designs process analyzers tailored to the agriculture industry [4] - Pro-Control produces solutions for in-situ chemical process control in industrial manufacturing [4] - BreathTech is advancing a breath analysis platform to detect volatile organic compounds (VOCs) associated with infections and critical health conditions [4] - EN-SCAN, Inc. delivers portable, ruggedized environmental testing solutions that integrate gas chromatography and mass spectrometry for use in challenging field environments [4] Investor Engagement - Thomas B. Pickens III, Chairman and CEO, and Jennifer Cañas, CFO, will host investor meetings on September 9, 2025, at the H.C. Wainwright 27th Annual Global Investment Conference in New York City [1] - Investors can register and request meetings with management via their HC Wainwright representative or Astrotech Investor Relations [2]

Core Points - Astrotech Corporation has appointed Jennifer Cañas as Chief Financial Officer effective May 22, 2025 [1] - The Board expressed confidence in Ms. Cañas' leadership and experience, highlighting her strong performance since joining the company [2] - Ms. Cañas has over 20 years of experience in senior financial roles, including her previous position as Controller at The Texas Water Company [2] - She is a Certified Public Accountant and graduated Cum Laude with a Bachelor of Science degree in accounting from the University of Houston – Clear Lake [3] - Ms. Cañas is committed to leading the team with integrity and aims to deliver value for shareholders [4] Company Overview - Astrotech Corporation is a mass spectrometry company that develops and commercializes scalable companies through its subsidiaries [4] - Subsidiaries include 1st Detect, AgLAB, Pro-Control, BreathTech, and EN-SCAN, each focusing on different markets such as security, agriculture, and environmental testing [4]